Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Head & Neck 1Gynecologic 1Genitourinary 1Dermatologic 1CNS 1Breast 1

Conditions

Leukemia, Myeloid, Acute 385Myelodysplastic Syndromes 153Leukemia, Myelomonocytic, Chronic 76Leukemia 65Recurrence 27Hematologic Neoplasms 20Myeloproliferative Disorders 18Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Anemia, Refractory, with Excess of Blasts 14Neoplasms 13Neoplasm, Residual 11Multiple Myeloma 11Leukemia, Monocytic, Acute 11Leukemia, Lymphocytic, Chronic, B-Cell 11Leukemia, Biphenotypic, Acute 11Lymphoma, Non-Hodgkin 10Leukemia, Myelomonocytic, Acute 10Primary Myelofibrosis 9Leukemia, Erythroblastic, Acute 9Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8Myelodysplastic-Myeloproliferative Diseases 8Lymphoma 8Leukemia, Myeloid 8Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8Leukemia, Megakaryoblastic, Acute 8Congenital Abnormalities 8Leukemia, Myelomonocytic, Juvenile 5Hodgkin Disease 5GATA2 Deficiency 5Lymphoma, Large B-Cell, Diffuse 4

Interventions

Therapeutics 5Flow Cytometry 5Cyclophosphamide 4Psychiatric Rehabilitation 3Polymerase Chain Reaction 3Methylprednisolone 3liposomal amphotericin B 2aflibercept 2Thiotepa 2Radiotherapy 2Prednisone 2Peripheral Blood Stem Cell Transplantation 2Ondansetron 2Melphalan 2Itraconazole 2Immunologic Techniques 2Immunoenzyme Techniques 2Etoposide 2Dexamethasone 2Caspofungin 2Carmustine 2Carboplatin 2Calcium Dobesilate 2Busulfan 2Aprepitant 2Amplified Fragment Length Polymorphism Analysis 2Alemtuzumab 2thymoglobulin 1sargramostim 1ixabepilone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Testicular Neoplasms × Azacitidine × Other hematologic neoplasm × Clear all
NCT02223052 2020-05-12

Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies

Celgene

Phase 1 Completed
89 enrolled
BreastCNSDermatologicGenitourinaryGynecologicHead & NeckLymphoidMyeloidOther hematologic neoplasmPlasma cellSarcomaThoracic

Urinary Bladder Neoplasms, Bone Neoplasms, Brain Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Glioblastoma, Hodgkin Disease, Kidney Neoplasms, Leukemia, Lung Neoplasms, Lymphoma, Lymphoma, Non-Hodgkin, Melanoma, Multiple Myeloma, Myelodysplastic Syndromes, Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Sarcoma, Osteosarcoma, Skin Neoplasms, Testicular Neoplasms, Thyroid Neoplasms, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡